Serum Institute of India Pvt. Ltd.
Serum Institute of India Pvt. Ltd.
Explore linked clinical trials.8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of a Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Recombinant Poliomyelitis and Haemophilus Influenzae Type b (Hib) Vaccine (SIIPL DTwP-HepB-rPV-Hib) | Diptheria Immunization; Haemophilus InfluenzaeType B Immunization; Hepatitis B Immunization; Pertussis Immunization; Polio Immunization; Tetanus Immunization | Not yet recruiting | Phase 1 / Phase 2 | 2026-10-06 | NCT07855172 | |
| Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 1 | 2026-09-29 | NCT07688369 | |
| Infant Malaria Vaccine Schedule Optimization | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 2 | 2026-09-29 | NCT06879327 | |
| Safety and Efficacy of wSp Vaccine in Young Children | Ear Diseases, otitis media, otorhinolaryngologic disease | Recruiting | Phase 2 | 2026-09-23 | NCT07216430 | |
| Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults | Prevention of Malaria Transmission and Clinical Malaria | Active, not recruiting | Phase 2 | 2026-07-08 | NCT07147400 | |
| Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 3 | 2026-06-29 | NCT06281119 | |
| Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine | Meningoccocal Disease | Recruiting | Not stated | 2026-06-03 | NCT07379151 | |
| An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine | Death, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2025-08-13 | NCT07009847 |